BRAFV600E-mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical response.


Institute for Systems Analysis and Computer Science "Antonio Ruberti", National Research Council, Rome, Italy. [Email]


Several studies have shown that different tumour types sharing a driver gene mutation do not respond uniformly to the same targeted agent. Our aim was to use an unbiased network-based approach to investigate this fundamental issue using BRAFV600E mutant tumours and the BRAF inhibitor vemurafenib.


BRAF V600E,Network medicine,Prediction of response,Vemurafenib,

OUR Recent Articles